BML Investment Partners, L.P.

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 427,432 shares
Security Ownership %: 1.4%

BML Investment Partners, L.P. ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

18 Jun 2025 - BML Investment Partners, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 427,432 shares of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX). This represents 1.4% ownership of the company. In their previous filing dated 30 May 2025, BML Investment Partners, L.P. had reported owning 3,217,423 shares, indicating a decrease of +87%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BML Investment Partners, L.P.	1.4%	-85%	$551,387	427,432	-2,789,991	-87%	$1.29	13D/A	17 Jun 2025	18 Jun 2025, 11:08
BML Investment Partners, L.P.	11%	-44%	$4,150,476	3,217,423	-2,532,009	-44%	$1.29	13D/A	28 May 2025	30 May 2025, 17:46
BML Investment Partners, L.P.	19%	-0.53%	$7,416,767	5,749,432	0		$1.29	13D	07 May 2025	07 May 2025, 10:27
BML Investment Partners, L.P.	19%		$7,416,767	5,749,432			$1.29	13G/A	31 Dec 2024	13 Feb 2025, 16:28